| Year |
Citation |
Score |
| 2015 |
Bergeron RJ, Bharti N, McManis JS, Wiegand J. Metabolically programmed iron chelators. Bioorganic & Medicinal Chemistry. 23: 5954-71. PMID 26231739 DOI: 10.1016/J.Bmc.2015.06.059 |
0.364 |
|
| 2014 |
Bergeron RJ, Wiegand J, McManis JS, Bharti N. Desferrithiocin: a search for clinically effective iron chelators. Journal of Medicinal Chemistry. 57: 9259-91. PMID 25207964 DOI: 10.1021/Jm500828F |
0.363 |
|
| 2012 |
Bergeron RJ, Wiegand J, Bharti N, McManis JS. Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles. Journal of Medicinal Chemistry. 55: 7090-103. PMID 22889170 DOI: 10.1021/Jm300509Y |
0.392 |
|
| 2011 |
Bergeron RJ, Wiegand J, Bharti N, McManis JS, Singh S. Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 24: 239-58. PMID 21103911 DOI: 10.1007/S10534-010-9389-Y |
0.368 |
|
| 2010 |
Bergeron RJ, Singh S, Bharti N, Jiang Y. Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators. Synthesis. 2010: 3631-3636. PMID 22013282 DOI: 10.1055/S-0030-1258245 |
0.373 |
|
| 2010 |
Bergeron RJ, Bharti N, Wiegand J, McManis JS, Singh S, Abboud KA. The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues. Journal of Medicinal Chemistry. 53: 2843-53. PMID 20232803 DOI: 10.1021/Jm9018146 |
0.352 |
|
| 2009 |
Bergeron RJ, Wiegand J, Singh S. Desferrithiocin analogue uranium decorporation agents. International Journal of Radiation Biology. 85: 348-61. PMID 19399680 DOI: 10.1080/09553000902781089 |
0.355 |
|
| 2008 |
Bergeron RJ, Wiegand J, McManis JS, Bharti N, Singh S. Desferrithiocin analogues and nephrotoxicity. Journal of Medicinal Chemistry. 51: 5993-6004. PMID 18788724 DOI: 10.1021/Jm8003398 |
0.341 |
|
| 2008 |
Bergeron RJ, Wiegand J, McManis JS, Bharti N, Singh S. Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues. Journal of Medicinal Chemistry. 51: 3913-23. PMID 18533709 DOI: 10.1021/Jm800154M |
0.373 |
|
| 2007 |
Bergeron RJ, Wiegand J, Bharti N, Singh S, Rocca JR. Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution. Journal of Medicinal Chemistry. 50: 3302-13. PMID 17564424 DOI: 10.1021/Jm070214S |
0.387 |
|
| 2007 |
Bergeron RJ, Bharti N, Singh S. Total Synthesis of Vulnibactin: A Natural Product Iron Chelator Synthesis. 2007: 1033-1037. DOI: 10.1055/S-2007-965960 |
0.342 |
|
| 2006 |
Bergeron RJ, Wiegand J, McManis JS, Bharti N. The design, synthesis, and evaluation of organ-specific iron chelators. Journal of Medicinal Chemistry. 49: 7032-43. PMID 17125256 DOI: 10.1021/Jm0608816 |
0.375 |
|
| 2006 |
Bergeron RJ, Wiegand J, McManis JS, Vinson JR, Yao H, Bharti N, Rocca JR. (S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity. Journal of Medicinal Chemistry. 49: 2772-83. PMID 16640338 DOI: 10.1021/Jm0508944 |
0.377 |
|
| 2005 |
Bergeron RJ, Bharti N, Wiegand J, McManis JS, Yao H, Prokai L. Polyamine-vectored iron chelators: the role of charge. Journal of Medicinal Chemistry. 48: 4120-37. PMID 15943485 DOI: 10.1021/Jm048974F |
0.4 |
|
| 2005 |
Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Park JH, Eiler-McManis E, Bergeron J, Brittenham GM. Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance. Journal of Medicinal Chemistry. 48: 821-31. PMID 15689166 DOI: 10.1021/Jm049306X |
0.391 |
|
| 2003 |
Bergeron RJ, McManis JS, Franklin AM, Yao H, Weimar WR. Polyamine-iron chelator conjugate. Journal of Medicinal Chemistry. 46: 5478-83. PMID 14640556 DOI: 10.1021/Jm0302694 |
0.389 |
|
| 2003 |
Bergeron RJ, Wiegand J, Weimar WR, McManis JS, Smith RE, Abboud KA. Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier. Chirality. 15: 593-9. PMID 12840823 DOI: 10.1002/Chir.10248 |
0.377 |
|
| 2003 |
Bergeron RJ, Wiegand J, McManis JS, Bussenius J, Smith RE, Weimar WR. Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency. Journal of Medicinal Chemistry. 46: 1470-7. PMID 12672247 DOI: 10.1021/Jm020412D |
0.373 |
|
| 2003 |
Bergeron RJ, Wiegand J, Weimar WR, Nguyen JN, Sninsky CA. Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model. Digestive Diseases and Sciences. 48: 399-407. PMID 12643622 DOI: 10.1023/A:1021908417220 |
0.315 |
|
| 2003 |
Bergeron RJ, Huang G, Weimar WR, Smith RE, Wiegand J, McManis JS. Desferrithiocin analogue based hexacoordinate iron(III) chelators. Journal of Medicinal Chemistry. 46: 16-24. PMID 12502356 DOI: 10.1021/Jm020184N |
0.363 |
|
| 2003 |
Bergeron RJ, Huang G, Smith RE, Bharti N, McManis JS, Butler A. Total synthesis and structure revision of petrobactin Tetrahedron. 59: 2007-2014. DOI: 10.1016/S0040-4020(03)00103-0 |
0.334 |
|
| 2003 |
Bergeron RJ, McManis JS, Weimar WR, Wiegand J, Eiler‐McManis E. Iron Chelators and Therapeutic Uses Burger's Medicinal Chemistry and Drug Discovery. 480-561. DOI: 10.1002/0471266949.Bmc051 |
0.383 |
|
| 2002 |
Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Huang G. Structure-activity relationships among desazadesferrithiocin analogues. Advances in Experimental Medicine and Biology. 509: 167-84. PMID 12572994 DOI: 10.1007/978-1-4615-0593-8_9 |
0.388 |
|
| 2002 |
Bergeron RJ, Wiegand J, Brittenham GM. HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning. Blood. 99: 3019-26. PMID 11929795 DOI: 10.1182/Blood.V99.8.3019 |
0.377 |
|
| 2001 |
Bergeron RJ, Wiegand J, Fannin TL. Control of irritable bowel syndrome with polyamine analogs: a structure-activity study. Digestive Diseases and Sciences. 46: 2615-2623. PMID 11768250 DOI: 10.1023/A:1012750723644 |
0.338 |
|
| 2001 |
Bergeron RJ, Xin MG, Weimar WR, Smith RE, Wiegand J. Significance of asymmetric sites in choosing siderophores as deferration agents. Journal of Medicinal Chemistry. 44: 2469-78. PMID 11448229 DOI: 10.1021/Jm010019S |
0.37 |
|
| 2001 |
Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Smith RE, Algee SE, Fannin TL, Slusher MA, Snyder PS. Polyamine analogue antidiarrheals: a structure-activity study. Journal of Medicinal Chemistry. 44: 232-44. PMID 11170633 DOI: 10.1021/jm000277 |
0.344 |
|
| 2001 |
Bergeron RJ, Müller R, McManis JS, Yao GW, Huang G. An Improved Synthesis of (3S,12S)-N¹,N14-Diethyl-3,12-dihydroxy-homospermine, a Polyamine Analogue Therapeutic Agent Synthesis. 2001: 1043-1048. DOI: 10.1055/S-2001-14570 |
0.344 |
|
| 2000 |
Bergeron RJ, Müller R, Bussenius J, McManis JS, Merriman RL, Smith RE, Yao H, Weimar WR. Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives. Journal of Medicinal Chemistry. 43: 224-35. PMID 10649978 DOI: 10.1021/Jm990375Z |
0.341 |
|
| 1999 |
Bergeron RJ, McManis JS, Bussenius J, Brittenham GM, Wiegand J. Evaluation of the desferrithiocin pharmacophore as a vector for hydroxamates. Journal of Medicinal Chemistry. 42: 2881-2886. PMID 10425097 DOI: 10.1021/Jm980611Q |
0.42 |
|
| 1999 |
Bergeron RJ, Wiegand J, McManis JS, McCosar BH, Weimar WR, Brittenham GM, Smith RE. Effects of C-4 stereochemistry and C-4' hydroxylation on the iron clearing efficiency and toxicity of desferrithiocin analogues. Journal of Medicinal Chemistry. 42: 2432-40. PMID 10395484 DOI: 10.1021/Jm990058S |
0.385 |
|
| 1999 |
Bergeron RJ, Wiegand J, Weimar WR, Vinson JR, Bussenius J, Yao GW, McManis JS. Desazadesmethyldesferrithiocin analogues as orally effective iron chelators. Journal of Medicinal Chemistry. 42: 95-108. PMID 9888836 DOI: 10.1021/Jm980340J |
0.404 |
|
| 1999 |
Bergeron RJ, Wiegand J, Brittenham GM. HBED: The Continuing Development of a Potential Alternative to Deferoxamine for Iron-Chelating Therapy Blood. 93: 370-375. DOI: 10.1182/Blood.V93.1.370.401K29_370_375 |
0.356 |
|
| 1999 |
Bergeron RJ, Bussenius J, Müller R, McCosar BH, McManis JS. (R)- and (S)-N-(Benzyloxycarbonyl)-3,4-epoxybutylamine. New 4-amino-2-hydroxybutyl synthons for the synthesis of hypusine reagents and (R)-6- and (S)-7-hydroxyspermidine Tetrahedron-Asymmetry. 10: 4285-4294. DOI: 10.1016/S0957-4166(99)00474-7 |
0.313 |
|
| 1998 |
Bergeron RJ, Wiegand J, Weimar WR, Snyder PS. Polyamine Analogue Antiarrhythmics Pharmacological Research. 38: 367-380. PMID 9806817 DOI: 10.1006/Phrs.1998.0384 |
0.306 |
|
| 1998 |
Bergeron RJ, Weimar WR, Müller R, Zimmerman CO, McCosar BH, Yao H, Smith RE. Effect of polyamine analogues on hypusine content in JURKAT T-cells. Journal of Medicinal Chemistry. 41: 3901-8. PMID 9748365 DOI: 10.1021/Jm980390O |
0.328 |
|
| 1998 |
Bergeron RJ, Weimar WR, Müller R, Zimmerman CO, McCosar BH, Yao H, Smith RE. Synthesis of reagents for the construction of hypusine and deoxyhypusine peptides and their application as peptidic antigens. Journal of Medicinal Chemistry. 41: 3888-900. PMID 9748364 DOI: 10.1021/Jm980389P |
0.318 |
|
| 1998 |
Bergeron RJ, Wiegand J, Ratliff‐Thompson K, Weimar WR. The Origin of the Differences in (R)- and (S)-Desmethyldesferrithiocin: Iron-Clearing Propertiesa Annals of the New York Academy of Sciences. 850: 202-216. PMID 9668541 DOI: 10.1111/J.1749-6632.1998.Tb10476.X |
0.344 |
|
| 1998 |
Bergeron RJ, Wiegand J, Brittenham GM. HBED: A Potential Alternative to Deferoxamine for Iron-Chelating Therapy Blood. 91: 1446-1452. DOI: 10.1182/Blood.V91.4.1446 |
0.381 |
|
| 1997 |
Fogel-Petrovic M, Kramer DL, Vujcic S, Miller J, Mcmanis JS, Bergeron RJ, Porter CW. Structural basis for differential induction of spermidine/spermine N1- acetyltransferase activity by novel spermine analogs Molecular Pharmacology. 52: 69-74. PMID 9224814 DOI: 10.1124/Mol.52.1.69 |
0.323 |
|
| 1997 |
Bergeron RJ, Feng Y, Weimar WR, McManis JS, Dimova H, Porter C, Raisler B, Phanstiel O. A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. Journal of Medicinal Chemistry. 40: 1475-94. PMID 9154970 DOI: 10.1021/Jm960849J |
0.372 |
|
| 1997 |
Bergeron RJ, Weimar WR, Wu Q, Feng Y, McManis JS. Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study. Journal of Medicinal Chemistry. 39: 5257-66. PMID 8978854 DOI: 10.1021/Jm960545X |
0.339 |
|
| 1997 |
Bergeron RJ, Xin M, Smith RE, Wollenweber M, McManis JS, Ludin C, Abboud KA. Total synthesis of rhizoferrin, an iron chelator Tetrahedron. 53: 427-434. DOI: 10.1016/S0040-4020(96)01061-7 |
0.411 |
|
| 1996 |
Bergeron RJ, Yao GW, Yao H, Weimar WR, Sninsky CA, Raisler B, Feng Y, Wu Q, Gao F. Metabolically programmed polyamine analogue antidiarrheals. Journal of Medicinal Chemistry. 39: 2461-71. PMID 8691443 DOI: 10.1021/Jm950827H |
0.327 |
|
| 1996 |
Bergeron RJ, Wiegand J, Wollenweber M, McManis JS, Algee SE, Ratliff-Thompson K. Synthesis and Biological Evaluation of Naphthyldesferrithiocin Iron Chelators Journal of Medicinal Chemistry. 39: 1575-1581. PMID 8648596 DOI: 10.1021/Jm9508752 |
0.405 |
|
| 1995 |
Bergeron RJ, Weimar WR, Wu Q, Austin JK, McManis JS. Impact of polyamine analogues on the NMDA receptor Journal of Medicinal Chemistry. 38: 425-428. PMID 7853334 DOI: 10.1021/Jm00003A004 |
0.314 |
|
| 1995 |
Bergeron RJ, McManis JS, Weimar WR, Schreier KM, Gao F, Wu Q, Ortiz-Ocasio J, Luchetta GR, Porter C, Vinson JRT. The role of charge in polyamine analogue recognition Journal of Medicinal Chemistry. 38: 2278-2285. PMID 7608892 DOI: 10.1021/Jm00013A003 |
0.351 |
|
| 1994 |
Bergeron RJ, Liu CZ, McManis JS, Xia MXB, Algee SE, Wiegand J. The desferrithiocin pharmacophore. Journal of Medicinal Chemistry. 37: 1411-1417. PMID 8182699 DOI: 10.1021/Jm00036A005 |
0.392 |
|
| 1994 |
Bergeron RJ, Wollenweber M, Wiegand J. An Investigation of Desferrithiocin Metabolism Journal of Medicinal Chemistry. 37: 2889-2895. PMID 8071936 DOI: 10.1021/Jm00044A009 |
0.318 |
|
| 1994 |
Bergeron RJ, McManis JS, Liu CZ, Feng Y, Weimar WR, Luchetta GR, Wu Q, Ortiz-Ocasio J, Vinson JR, Kramer D. Antiproliferative properties of polyamine analogues: a structure-activity study. Journal of Medicinal Chemistry. 37: 3464-76. PMID 7932575 DOI: 10.1021/Jm00047A004 |
0.367 |
|
| 1993 |
Albanese L, Bergeron RJ, Pegg AE. Investigations of the mechanism by which mammalian cell growth is inhibited by N1N12-bis(ethyl)spermine. The Biochemical Journal. 131-7. PMID 8471032 DOI: 10.1042/Bj2910131 |
0.304 |
|
| 1993 |
Chang BK, Liang Y, Miller DW, Bergeron RJ, Porter CW, Wang G. Effects of diethyl spermine analogues in human bladder cancer cell lines in culture. The Journal of Urology. 150: 1293-7. PMID 8371417 DOI: 10.1016/S0022-5347(17)35763-4 |
0.345 |
|
| 1993 |
Bergeron RJ, Streiff RR, King W, Daniels RD, Wiegand J. A Comparison of the Iron-Clearing Properties of Parabactin and Desferrioxamine Blood. 82: 2552-2557. DOI: 10.1182/Blood.V82.8.2552.2552 |
0.346 |
|
| 1993 |
Bergeron R, Streiff R, Creary E, Daniels R, King W, Luchetta G, Wiegand J, Moerker T, Peter H. A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model Blood. 81: 2166-2173. DOI: 10.1182/Blood.V81.8.2166.2166 |
0.348 |
|
| 1992 |
Chang BK, Bergeron RJ, Porter CW, Vinson JR, Liang Y, Libby PR. Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines. Cancer Chemotherapy and Pharmacology. 30: 183-8. PMID 1628366 DOI: 10.1007/Bf00686309 |
0.333 |
|
| 1992 |
Chang BK, Bergeron RJ, Porter CW, Liang Y. Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models. Cancer Chemotherapy and Pharmacology. 30: 179-82. PMID 1628365 DOI: 10.1007/Bf00686308 |
0.327 |
|
| 1992 |
Bergeron RJ, Liu ZR, McManis JS, Wiegand J. Structural alterations in desferrioxamine compatible with iron clearance in animals. Journal of Medicinal Chemistry. 35: 4739-4744. PMID 1469701 DOI: 10.1021/Jm00103A012 |
0.404 |
|
| 1992 |
Bergeron R, Streiff R, Wiegand J, Luchetta G, Creary E, Peter H. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine. Blood. 79: 1882-1890. DOI: 10.1182/Blood.V79.7.1882.1882 |
0.357 |
|
| 1992 |
Bergeron RJ, Phanstiel O. The total synthesis of nannochelin: a novel cinnamoyl hydroxamate-containing siderophore Journal of Organic Chemistry. 57: 7140-7143. DOI: 10.1021/Jo00052A030 |
0.362 |
|
| 1991 |
Bergeron RJ, Wiegand J, Dionis JB, Egli-Karmakka M, Frei J, Huxley-Tencer A, Peter HH. Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators. Journal of Medicinal Chemistry. 34: 2072-2078. PMID 2066978 DOI: 10.1021/Jm00111A023 |
0.4 |
|
| 1991 |
Libby PR, Ganis B, Bergeron RJ, Porter CW. Characterization of human spermidine/spermine N1-acetyltransferase purified from cultured melanoma cells. Archives of Biochemistry and Biophysics. 284: 238-44. PMID 1989509 DOI: 10.1016/0003-9861(91)90291-P |
0.325 |
|
| 1991 |
Bergeron RJ, Weimar WR. Increase in spermine content coordinated with siderophore production in Paracoccus denitrificans. Journal of Bacteriology. 173: 2238-2243. PMID 1826103 DOI: 10.1128/Jb.173.7.2238-2243.1991 |
0.355 |
|
| 1990 |
Porter CW, Pegg AE, Ganis B, Madhabala R, Bergeron RJ. Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue N1 N12-bis(ethyl)spermine. The Biochemical Journal. 268: 207-12. PMID 2344358 DOI: 10.1042/Bj2680207 |
0.329 |
|
| 1990 |
Pegg AE, Pakala R, Bergeron RJ. Induction of spermidine/spermine N1-acetyltransferase activity in Chinese-hamster ovary cells by N1N11-bis(ethyl)norspermine (corrected) and related compounds. The Biochemical Journal. 267: 331-8. PMID 2334396 DOI: 10.1042/Bj2670331 |
0.36 |
|
| 1990 |
Bergeron RJ, Weimar WR. Kinetics of iron acquisition from ferric siderophores by Paracoccus denitrificans. Journal of Bacteriology. 172: 2650-2657. PMID 2185228 DOI: 10.1128/Jb.172.5.2650-2657.1990 |
0.321 |
|
| 1990 |
Bergeron RJ, Streiff RR, Wiegand J, Vinson JR, Luchetta G, Evans KM, Peter H, Jenny HB. A comparative evaluation of iron clearance models. Annals of the New York Academy of Sciences. 612: 378-93. PMID 2127168 DOI: 10.1111/J.1749-6632.1990.Tb24325.X |
0.333 |
|
| 1990 |
Bergeron RJ, McManis JS. The total synthesis of desferrioxamines E and G Tetrahedron. 46: 5881-5888. DOI: 10.1016/S0040-4020(01)87913-8 |
0.328 |
|
| 1989 |
Libby PR, Bergeron RJ, Porter CW. Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity. Biochemical Pharmacology. 38: 1435-42. PMID 2497746 DOI: 10.1016/0006-2952(89)90182-2 |
0.351 |
|
| 1989 |
Bergeron RJ, McManis JS. The total synthesis of bisucaberin Tetrahedron. 45: 4939-4944. DOI: 10.1016/S0040-4020(01)81074-7 |
0.363 |
|
| 1988 |
Bergeron RJ, Weimar WR, Dionis JB. Demonstration of ferric L-parabactin-binding activity in the outer membrane of Paracoccus denitrificans. Journal of Bacteriology. 170: 3711-3717. PMID 3403511 DOI: 10.1128/Jb.170.8.3711-3717.1988 |
0.311 |
|
| 1988 |
Bergeron RJ, Neims AH, McManis JS, Hawthorne TR, Vinson JR, Bortell R, Ingeno MJ. Synthetic polyamine analogues as antineoplastics. Journal of Medicinal Chemistry. 31: 1183-90. PMID 3373487 DOI: 10.1021/Jm00401A019 |
0.341 |
|
| 1988 |
Chang BK, Libby PR, Bergeron RJ, Porter CW. Modulation of polyamine biosynthesis and transport by oncogene transfection. Biochemical and Biophysical Research Communications. 157: 264-70. PMID 3143363 DOI: 10.1016/S0006-291X(88)80042-1 |
0.308 |
|
| 1987 |
Vertino PM, Bergeron RJ, Cavanaugh PF, Porter CW. Structural determinants of spermidine-DNA interactions Biopolymers - Peptide Science Section. 26: 691-703. PMID 3593890 DOI: 10.1002/Bip.360260510 |
0.33 |
|
| 1987 |
Porter CW, Berger FG, Pegg AE, Ganis B, Bergeron RJ. Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine Biochemical Journal. 242: 433-440. PMID 3036091 DOI: 10.1042/Bj2420433 |
0.312 |
|
| 1987 |
Bergeron RJ, McManis JS. Total synthesis of (.+-.)-15-deoxyspergualin Journal of Organic Chemistry. 52: 1700-1703. DOI: 10.1021/Jo00385A010 |
0.341 |
|
| 1986 |
Bergeron RJ, Braylan R, Goldey S, Ingeno M. Effects of the vibriocholerae siderophore vibriobactin on the growth characteristics of L1210 cells Biochemical and Biophysical Research Communications. 136: 273-280. PMID 3707576 DOI: 10.1016/0006-291X(86)90905-8 |
0.377 |
|
| 1986 |
Bergeron RJ. Iron: a controlling nutrient in proliferative processes Trends in Biochemical Sciences. 11: 133-136. DOI: 10.1016/0968-0004(86)90067-8 |
0.31 |
|
| 1985 |
Bergeron RJ, Streiff RR, Elliott GT. Influence of iron on in vivo proliferation and lethality of L1210 cells. Journal of Nutrition. 115: 369-374. PMID 3973748 DOI: 10.1093/Jn/115.3.369 |
0.351 |
|
| 1985 |
Bergeron RJ, Mcmanis JS, Dionis JB, Garlich JR. An efficient total synthesis of agrobactin and its gallium(III) chelate Journal of Organic Chemistry. 50: 2780-2782. DOI: 10.1021/Jo00215A037 |
0.301 |
|
| 1985 |
Bergeron RJ, Garlich JR, McManis JS. Total synthesis of vibriobactin Tetrahedron. 41: 507-510. DOI: 10.1016/S0040-4020(01)96492-0 |
0.355 |
|
| 1985 |
Bergeron RJ, Mcmanis JS, Dionis JB, Garlich JR. An Efficient Total Synthesis Of Agrobactin And Its Gallium(Iii) Chelate Cheminform. 16. DOI: 10.1002/Chin.198552316 |
0.301 |
|
| 1984 |
Casero RA, Bergeron RJ, Porter CW. Treatment with α-difluoromethylornithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells Journal of Cellular Physiology. 121: 476-482. PMID 6438117 DOI: 10.1002/Jcp.1041210305 |
0.31 |
|
| 1984 |
Bergeron RJ, Gavanaugh PF, Kline SJ, Hughes RG, Elliott GT, Porter CW. Antineoplastic and antiherpetic activity of spermidine catecholamide iron chelators Biochemical and Biophysical Research Communications. 121: 848-854. PMID 6331431 DOI: 10.1016/0006-291X(84)90755-1 |
0.383 |
|
| 1984 |
Bergeron RJ, Garlich JR, Stolowich NJ. Reagents for the stepwise functionalization of spermidine, homospermidine, and bis(3-aminopropyl)amine Journal of Organic Chemistry. 49: 2997-3001. DOI: 10.1021/Jo00190A028 |
0.326 |
|
| 1983 |
Bergeron RJ, Elliott GT, Kline SJ, Ramphal R, James LS. Bacteriostatic and fungostatic action of catecholamide iron chelators. Antimicrobial Agents and Chemotherapy. 24: 725-730. PMID 6419673 DOI: 10.1128/Aac.24.5.725 |
0.365 |
|
| 1983 |
BERGERON RJ, STOLOWICH NJ, PORTER CW. ChemInform Abstract: REAGENTS FOR THE SELECTIVE SECONDARY N-ACYLATION OF LINEAR TRIAMINES Chemischer Informationsdienst. 14. DOI: 10.1002/Chin.198301142 |
0.31 |
|
| 1981 |
Bergeron RJ, Kline SJ, Stolowich NJ, McGovern KA, Burton PS. Flexible Synthesis Of Polyamine Catecholamides Journal of Organic Chemistry. 13: 4524-4529. DOI: 10.1021/Jo00335A041 |
0.309 |
|
| 1981 |
Bergeron RJ, Burton PS, Kline SJ, McGovern KA. Biomimetic synthesis of a Paracoccus denitrificans siderophore analog Journal of Organic Chemistry. 13: 3712-3718. DOI: 10.1021/Jo00331A026 |
0.325 |
|
| 1981 |
Bergeron RJ, Burton PS, Mcgovern KA, Onge EJS, Streiff RR. Synthesis, Absorption, And Toxicity Of N1,N8-Bis(2,3-Dihydroxybenzoyl)Spermidine, A Potent Iron Chelator Cheminform. 12. DOI: 10.1002/Chin.198110223 |
0.415 |
|
| 1980 |
Bergeron RJ, McGovern KA, Channing MA, Burton PS. Synthesis of N4-acylated N1,N8-bis(acyl)spermidines. An approach to the synthesis of siderophores Journal of Organic Chemistry. 11: 1589-1592. DOI: 10.1021/Jo01297A008 |
0.353 |
|
| 1980 |
Bergeron RJ, Hoffman PG. The application of N-phenyltriflamide to the synthesis of deoxyaspergillic acid Journal of Organic Chemistry. 45: 163-165. DOI: 10.1021/Jo01289A033 |
0.339 |
|
| 1980 |
Bergeron RJ, Hoffman P. Application of N-phenyltrifluoromethanesulfonamides to the synthesis of pyrazines Journal of Organic Chemistry. 45: 161-163. DOI: 10.1021/Jo01289A032 |
0.342 |
|
| 1980 |
Bergeron RJ, Hoffman P. Application of N-phenyltrifluoromethanesulfonamides to the synthesis of pyrazines Cheminform. 11. DOI: 10.1002/Chin.198025244 |
0.342 |
|
| 1975 |
Hendrickson JB, Bergeron R, Sternbach DD. New "Gabriel" syntheses of amines Tetrahedron. 31: 2517-2521. DOI: 10.1016/0040-4020(75)80263-8 |
0.322 |
|
| 1973 |
Hendrickson JB, Bergeron R. Triflamides for protection and monoalkylation of amines and a new gabriel synthesis. Tetrahedron Letters. 14: 3839-3842. DOI: 10.1016/S0040-4039(01)87051-9 |
0.305 |
|
| Show low-probability matches. |